These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23031595)

  • 1. Design, synthesis, and evaluation of potential prodrugs of DFMO for reductive activation.
    Yang Y; Voak A; Wilkinson SR; Hu L
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6583-6. PubMed ID: 23031595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs.
    Hu L; Wu X; Han J; Chen L; Vass SO; Browne P; Hall BS; Bot C; Gobalakrishnapillai V; Searle PF; Knox RJ; Wilkinson SR
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3986-91. PubMed ID: 21620697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.
    Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L
    J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives.
    Wilkinson SR; Bot C; Kelly JM; Hall BS
    Curr Top Med Chem; 2011; 11(16):2072-84. PubMed ID: 21619510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
    Johansson E; Parkinson GN; Denny WA; Neidle S
    J Med Chem; 2003 Sep; 46(19):4009-20. PubMed ID: 12954054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
    Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
    Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
    Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA
    J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Chatelain E; Kaiser M; Wilkinson SR; McKenzie C; Ioset JR
    J Med Chem; 2012 Jun; 55(11):5554-65. PubMed ID: 22550999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the substrate preference of a type I nitroreductase to develop antitrypanosomal quinone-based prodrugs.
    Hall BS; Meredith EL; Wilkinson SR
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5821-30. PubMed ID: 22948871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase.
    Hay MP; Atwell GJ; Wilson WR; Pullen SM; Denny WA
    J Med Chem; 2003 Jun; 46(12):2456-66. PubMed ID: 12773049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An essential type I nitroreductase from Leishmania major can be used to activate leishmanicidal prodrugs.
    Voak AA; Gobalakrishnapillai V; Seifert K; Balczo E; Hu L; Hall BS; Wilkinson SR
    J Biol Chem; 2013 Oct; 288(40):28466-76. PubMed ID: 23946481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmaceutical properties of N-acyloxymethyl prodrugs of Allop with potential anti-trypanosomal activity.
    Gualdesi MS; Ortiz CS; Raviolo MA
    Drug Dev Ind Pharm; 2016; 42(4):602-10. PubMed ID: 26181622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitroaryl phosphoramides as novel prodrugs for E. coli nitroreductase activation in enzyme prodrug therapy.
    Hu L; Yu C; Jiang Y; Han J; Li Z; Browne P; Race PR; Knox RJ; Searle PF; Hyde EI
    J Med Chem; 2003 Nov; 46(23):4818-21. PubMed ID: 14584930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro evaluation of potential antichagasic hydroxymethylnitrofurazone (NFOH-121): a new nitrofurazone prodrug.
    Chung MC; Güido RV; Martinelli TF; Gonçalves MF; Polli MC; Botelho KC; Varanda EA; Colli W; Miranda MT; Ferreira EI
    Bioorg Med Chem; 2003 Nov; 11(22):4779-83. PubMed ID: 14556793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of existing antibiotics in the form of precursor prodrugs that can be subsequently activated by nitroreductases of the target pathogen.
    Çelik A; Yetiş G; Ay M; Güngör T
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4057-60. PubMed ID: 27390065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation.
    Hall BS; Wilkinson SR
    Antimicrob Agents Chemother; 2012 Jan; 56(1):115-23. PubMed ID: 22037852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of anticancer prodrugs for reductive activation.
    Chen Y; Hu L
    Med Res Rev; 2009 Jan; 29(1):29-64. PubMed ID: 18688784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 4-substituted analogues of 5-[N,N-bis (2-chloroethyl)amino]-2-nitrobenzamide as bioreductively activated prodrugs using an Escherichia coli nitroreductase.
    Atwell GJ; Boyd M; Palmer BD; Anderson RF; Pullen SM; Wilson WR; Denny WA
    Anticancer Drug Des; 1996 Oct; 11(7):553-67. PubMed ID: 8921936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of dihydronaphthofurandiones and dihydrofuroquinolinediones with trypanocidal activity and analysis of their stereoelectronic properties.
    Tapia RA; Salas C; Morello A; Maya JD; Toro-Labbé A
    Bioorg Med Chem; 2004 May; 12(9):2451-8. PubMed ID: 15080940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrobenzocyclophosphamides as potential prodrugs for bioreductive activation: synthesis, stability, enzymatic reduction, and antiproliferative activity in cell culture.
    Li Z; Han J; Jiang Y; Browne P; Knox RJ; Hu L
    Bioorg Med Chem; 2003 Sep; 11(19):4171-8. PubMed ID: 12951148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.